Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Brio Pharmaceuticals Inc
FDA Inspection
•Brio Pharmaceuticals Inc•March 21, 2014

Brio Pharmaceuticals Inc – FDA Inspection, Mar 21, 2014

Record Details

This FDA Inspection record concerns Brio Pharmaceuticals Inc, with an inspection on March 21, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Brio Pharmaceuticals Inc
Inspection Date
March 21, 2014
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · f1a22335-8abf-4920-9fe0-cf78e284376b

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
871072
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

11
  1. 21 CFR 211.25(a)Training--operations, GMPs, written procedures
  2. 21 CFR 211.194(a)(8)Identification of Person Performing Review of Lab Records
  3. 21 CFR 211.194(a)Complete test data included in records
  4. 21 CFR 211.113(a)Procedures for non-sterile drug products
  5. 21 CFR 211.180(e)Records reviewed annually
  6. 21 CFR 211.165(e)Test methods
  7. 21 CFR 211.192Investigations of discrepancies, failures
  8. 21 CFR 211.42(c)Defined areas of adequate size for operations
  9. 21 CFR 211.80(a)Procedures To Be in Writing
  10. 21 CFR 211.67(b)Written procedures not established/followed

Showing 10 of 11 citations.

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Brio Pharmaceuticals Inc

10
DateClassificationOfficeProject area
June 19, 2026Not classifiedDallas District Office
February 27, 2026VAIDallas District OfficeDrug Quality Assurance
July 11, 2019VAICenter for Drug Evaluation and ResearchGeneric Drug Evaluation
October 3, 2018VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
April 26, 2017Not classifiedDallas District OfficeDrug Quality Assurance
View all 10 other inspections on the company page
Other documents for Brio Pharmaceuticals Inc
  • FDA Inspection 1323564 - 2026-06-19
  • FDA Inspection 1304746 - 2026-02-27
  • FDA Inspection 1096432 - 2019-07-11
  • FDA Inspection 1067624 - 2018-10-03
  • FDA Inspection 1011466 - 2017-04-26

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Brio Pharmaceuticals Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.